OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
Luis F. González, Lorenzo E. Bevilacqua, Rodrigo Naves
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2055-2055
Open Access | Times Cited: 15

Showing 15 citing articles:

Mitochondria-targeted senotherapeutic interventions
Mehmet Can Atayik, Ufuk Çakatay
Biogerontology (2022) Vol. 23, Iss. 4, pp. 401-423
Closed Access | Times Cited: 39

Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease
Ghulam Mustafa Channa, Dilawar Hassan, Mahira Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104774-104774
Open Access | Times Cited: 31

Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques
Camilla Pegoraro, Inés Domingo-Ortí, Inmaculada Conejos‐Sánchez, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115195-115195
Open Access | Times Cited: 9

The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence
Allison R. Hanaford, Simon C. Johnson
Orphanet Journal of Rare Diseases (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 28

Pharmacological approaches to enhance mitochondrial biogenesis: focus on PGC-1Α, AMPK, and SIRT1 in cellular health
Ahmet Alperen Palabiyik, Esra Palabıyık
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Capacity of fullerenols to modulate neurodegeneration induced by ferroptosis: focus on multiple sclerosis
Mariana Seke, Aleksandra Stanković, Maja Živković
Multiple Sclerosis and Related Disorders (2025), pp. 106378-106378
Closed Access

Common methods in mitochondrial research (Review)
Yiyuan Yin, Haitao Shen
International Journal of Molecular Medicine (2022) Vol. 50, Iss. 4
Open Access | Times Cited: 25

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
Anamaria Jurcău, CarolinaMaria Jurcau
Neural Regeneration Research (2022) Vol. 18, Iss. 7, pp. 1472-1472
Open Access | Times Cited: 24

The role of mitochondrial dynamics in disease
Yujuan Wang, Xinyan Dai, Hui Li, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 11

Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets
Xiaolei Gu, Qi Long, Qing Qi, et al.
BioScience Trends (2024) Vol. 18, Iss. 1, pp. 49-65
Open Access | Times Cited: 3

Mitochondria-associated cellular senescence mechanisms: Biochemical and pharmacological perspectives
Mehmet Can Atayik, Ufuk Çakatay
Advances in protein chemistry and structural biology (2023), pp. 117-155
Closed Access | Times Cited: 7

Breaking the resistance: integrative approaches with novel therapeutics against Klebsiella pneumoniae
V. K. Koul, Apoorva Sharma, Diksha Kumari, et al.
Archives of Microbiology (2024) Vol. 207, Iss. 1
Closed Access | Times Cited: 1

Nanodiagnostics and nanomedicines for neurodegenerative disorders
Kunjbihari Sulakhiya, Anglina Kisku, Rishi Paliwal, et al.
Elsevier eBooks (2023), pp. 131-163
Closed Access | Times Cited: 4

Nanopharmacology as a new approach to treat neuroinflammatory disorders
Sebastián García Menéndez, Walter Manucha
Translational Neuroscience (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Page 1

Scroll to top